The quarter materially beat the standing outlook. Management had guided to roughly $73–77 million of revenue, about $1.5 million of adjusted EBITDA, approximately $27 million of non-GAAP operating expenses, and an adjusted loss of roughly $0.15 per share. Revenue reached $80.8 million, adjusted EBITDA $8.0 million, adjusted operating expenses $25.1 million, and adjusted EPS $0.18 — a broad beat rather than a single-line outperformance.
| Metric | Q1 FY2027 actual | Prior expectation / comparison |
|---|---|---|
| Revenue | $80.8 million (Income Statement) | Guidance: $73–77 million; midpoint ~$75 million |
| Gross profit / margin | $31.7 million / 39.3% (Income Statement) | $22.7 million / 35.3% prior year |
| GAAP operating expenses | $26.7 million (Income Statement) | Guidance: ~$26–28 million |
| Non-GAAP operating expenses | $25.1 million (Non-GAAP operating expenses) | Guidance: ~$26–28 million |
| Adjusted EBITDA | $8.0 million (Adjusted EBITDA reconciliation) | Guidance: ~$0.5–2.5 million; midpoint ~$1.5 million |
| Adjusted net income / EPS | $4.0 million / $0.18 (Non-GAAP adjusted net income reconciliation) | Guidance: adjusted EPS of roughly $(0.25)–$(0.05) |
| GAAP net loss / EPS | $(155.3) million / $(7.06) (Income Statement) | Distorted by debt-related accounting charges |
The operating improvement was real, not just accounting cleanup. Revenue grew 26% year over year, gross margin expanded 400 basis points to 39.3%, and GAAP operating income turned positive at $5.0 million from a $12.6 million loss. Operating expenses fell to $26.7 million from $35.3 million, while operating cash flow turned positive at $0.9 million versus a $16.9 million use of cash in the prior-year quarter. (Income Statement) (Cash Flow statement)
The headline GAAP loss is misleading, but the balance-sheet repair is meaningful. The $155.3 million net loss included $129.7 million from convertible-note fair-value changes, $16.3 million from warrant revaluation, and an $11.7 million debt-extinguishment loss. (Income Statement) Those charges were largely non-cash, while term debt and the convertible note fell to zero and cash rose to $54.6 million. (Balance Sheet) The debt elimination was already part of the recent capital restructuring, so it is more confirmation of the cleanup than a new surprise in this filing.
Shareholder economics are the main offset to the strong operating beat. The convertible-note settlement issued 14.1 million common shares, lifting shares outstanding to 39.4 million from 14.6 million at March 31, 2026; weighted-average shares also more than doubled to 22.0 million. (Cash Flow statement) The company now has a much less leveraged balance sheet, but it still reported a $27.8 million stockholders’ deficit and $31.7 million of warrant liabilities. (Balance Sheet) Net result: a clearly better-than-expected operating quarter and liquidity position, tempered by substantial dilution and residual warrant overhang.
Read the original 8-K on SEC EDGAR ↗